Literature DB >> 16918763

Postinfectious irritable bowel syndrome may occur after non-gastrointestinal and intestinal infection.

E S McKeown1, S D Parry, R Stansfield, J R Barton, M R Welfare.   

Abstract

Postinfectious functional gastrointestinal disorders (FGIDs) may not be specific to gastroenteritis. This pilot study aimed to ascertain the 3- and 6-month incidence of functional gut disorders in people with non-gastrointestinal (GI) infection, gastroenteritis and healthy controls. This was a prospective study of three cohorts recruited from hospital (non-GI infections) and the community (others). FGIDs were diagnosed using self-completed Rome II modular questionnaires administered at baseline, 3 and 6 months. Thirty-six subjects with non-GI infection, 219 healthy subjects and 108 with bacterial gastroenteritis participated. No difference in incidence of FGID was detected between the GI and non-GI infection cohorts. Any FGID was more frequent in people who had a non-GI infection than in controls at both 3 [odds ratio: 4.34 (95% CI: 3.60-16.45)] and 6 months [4.76 (4.42-27.92)]. Irritable bowel syndrome (IBS) alone was more frequent in people with non-GI infections than in controls at 3 months (6.12 [1.30-29.12]) but did not quite reach statistical significance at 6 months (4.58 [0.79-26.46]). Our findings were unexpected. Postinfectious FGIDs may be related to non-GI and GI infection, although not all potential biases were controlled in study design. Further studies need to explore these preliminary findings and, if confirmed, the underlying mechanisms.

Entities:  

Mesh:

Year:  2006        PMID: 16918763     DOI: 10.1111/j.1365-2982.2006.00821.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  13 in total

1.  Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora?

Authors:  Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

2.  Cognitive behavioural model of irritable bowel syndrome.

Authors:  Francis Creed
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

3.  Bacterial infections in childhood: A risk factor for gastrointestinal and other diseases?

Authors:  Juliane Schwille-Kiuntke; Alexandra Unverdorben; Katja Weimer; Angelika Anita Schlarb; Marco Daniel Gulewitsch; Ute Ellert; Paul Enck
Journal:  United European Gastroenterol J       Date:  2015-02       Impact factor: 4.623

4.  From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome.

Authors:  Oscar Rodríguez-Fandiño; Joselín Hernández-Ruiz; Max Schmulson
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

5.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

Review 6.  Carbohydrate malabsorption in patients with non-specific abdominal complaints.

Authors:  Peter Born
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

7.  Discrepancies between the responses to skin prick test to food and respiratory antigens in two subtypes of patients with irritable bowel syndrome.

Authors:  Rosa-Ls Soares; Hamilton-N Figueiredo; Jose-M Santos; Rita-F Oliveira; Raquel-L Godoy; Felipe-Ap Mendonca
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

8.  Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders.

Authors:  H Paula; M Grover; S L Halder; G R Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2015-08-24       Impact factor: 3.598

Review 9.  Irritable bowel syndrome: emerging paradigm in pathophysiology.

Authors:  Yoo Jin Lee; Kyung Sik Park
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Relative risk of irritable bowel syndrome following acute gastroenteritis and associated risk factors.

Authors:  B K Kowalcyk; H M Smeets; P A Succop; N J De Wit; A H Havelaar
Journal:  Epidemiol Infect       Date:  2013-08-13       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.